News

Deal Announcements

Aquinox Pharma Adds $14 Million Venture Capital

Wednesday, April 3, 2013 5:32:00 AM PDT | VentureDeal
   Richmond, BC, Canada  --  Aquinox Pharmaceuticals has secured $14 million in new venture capital investment, according to an SEC regulatory filing.

Aquinox is developing small molecule therapeutics for the treatment of inflammatory disease and cancers.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Aquinox is still seeking $7 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1